Revised: 7 November 2019
Information for Healthcare Professionals
This section provides information useful to healthcare professionals.
Medsafe Advice
| Date | Type | Title |
|---|---|---|
| 4/06/2020 | Publications | Prescriber Update 41(2) - June 2020 |
| 28/05/2020 | Alert Communication | Miracle Mineral Solution - dangerous and potentially life-threatening side effects |
| 21/05/2020 | Monitoring Communication | Update - Possible risk of vasculitis with dabigatran (Pradaxa) |
| 21/05/2020 | Monitoring Communication |  Potential interaction between fluoxetine and
levothyroxine |
| 1/05/2020 | Dear Healthcare Professional Letter | Use of Hydroxychloroquine [Plaquenil] in the context of COVID 19 - Risk of QT prolongation and drug/drug interactions (PDF, 4 pages, 358 KB) |
| 29/04/2020 | Committees | Minutes of the 181st Medicines Adverse Reactions Committee meeting |
| 22/04/2020 | Medicines | COVID-19 - point of care test kits - restriction on importation, manufacture, supply and use |
If you have an enquiry that is not answered by the information on the web site please contact us at askmedsafe@health.govt.nz.
